Table 3 Cox proportional hazards multiple regression, with overall survival as outcome variable.
From: Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer
Variable | Hazard Ratio | 95% CI | P | |
---|---|---|---|---|
SQLE GE | High vs. Low | 1.32 | 1.03–1.68 | 0.0267 * |
Intermediate vs. Low | 1.10 | 0.86–1.42 | 0.4527 | |
Age | <50 vs. 50–64 years–old | 1.17 | 0.91–1.51 | 0.2402 |
65 or > vs. 50–64 years–old | 1.31 | 1.04–1.64 | 0.0199 * | |
T size | T2 or > vs. T1 | 1.45 | 1.13–1.84 | 0.0028 ** |
NPLN | 1–3 vs. 0 | 1.66 | 1.32–2.09 | 1.43 × 10−5 *** |
4 or > vs. 0 | 3.47 | 2.71–4.43 | <2 × 10−16 *** | |
Grade | High vs. Low/Intermediate | 1.19 | 0.96–1.48 | 0.1155 |
ER status | Positive vs. Negative | 0.71 | 0.56–0.91 | 0.0064 ** |
Her2 status | Positive vs. Negative | 1.58 | 1.23–2.02 | 0.0003 *** |